Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Federal Reserve Crisis: DOJ Standoff Threatens Powell's Succession and Rate Stability 
Stellantis Shareholder Fraud Lawsuit Dismissed by U.S. Judge 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
Maduro Faces Rare Narcoterrorism Charges in U.S. Court 
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty 
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge 
The four types of dementia most people don’t know exist 
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss 
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions 
Federal Reserve Hires Robert Hur to Fight DOJ Subpoenas Targeting Jerome Powell 
U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising 
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
Estée Lauder Sues Jo Malone Over Trademark Dispute Involving Zara 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
